Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Phase III study of Gattex demonstrates clinical benefits

Oct. 16, 2007

New agents for treating gastrointestinal disorders reported in recent patents

Oct. 10, 2007

Loss of T-bet function leads to a communicable form of ulcerative colitis in mice / News in Context

Oct. 9, 2007

Top-line results reported for granulated mesalamine in ulcerative colitis

Oct. 9, 2007

Dosing begins in phase III registration studies for clevudine

Oct. 8, 2007

New agents for treating gastrointestinal disorders reported in recent patents

Oct. 8, 2007

First patient dosed in phase III trial of AGI-003 for IBS-D

Oct. 8, 2007

Pharmasset commences combination study of R-7128 for HCV treatment

Oct. 5, 2007

First patients enrolled in Transgene's phase I trial of HCV vaccine TG-4040

Oct. 3, 2007

NPS licenses rights to Gattex outside of North America to Nycomed

Oct. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...